BioInvent International AB (publ) (LON:0H22)
London · Delayed Price · Currency is GBP · Price in SEK 44.54
0.00 (0.00%)
Jul 18, 2022, 5:13 PM GMT
LON:0H22 Market Cap
LON:0H22 has a market cap or net worth of 139.24 million as of February 12, 2026. Its market cap has increased by 2.35% in one year.
Market Cap
139.24M
Enterprise Value
83.38M
Revenue
19.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
44.54
Market Cap Chart
Since June 14, 2001, LON:0H22's market cap has increased from 80.35M to 139.24M, an increase of 73.30%. That is a compound annual growth rate of 2.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 139.24M | -10.88% |
| Dec 30, 2025 | 156.23M | -14.77% |
| Dec 30, 2024 | 183.30M | 88.74% |
| Dec 29, 2023 | 97.12M | -41.42% |
| Dec 30, 2022 | 165.78M | -25.08% |
| Dec 30, 2021 | 221.27M | 40.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PureTech Health | 312.74M |
| Avacta Group | 260.26M |
| Scancell Holdings | 128.68M |
| Bioventix | 92.74M |
| 4basebio | 91.32M |
| Faron Pharmaceuticals Oy | 77.58M |
| Hemogenyx Pharmaceuticals | 57.51M |
| SkinBioTherapeutics | 51.13M |